This announcement is a separate document:
华兰疫苗：监事会关于公司2022年限制性股票激励计划首次授予部分第一个归属期归属对象名单的核查意见
Hualan Biological Vaccine Inc.: The Supervisory Board's review opinion on the company's 2022 restricted stock incentive plan granted part of the first vesting period list for the first time
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated